Table 1.

Dermatological Manifestations Reported with CDK4/6 Inhibitors

● Alopecia

● Vitiligo

● Acute bullous skin rash

● Stevens–Johnson syndrome (SJS)

● Toxic epidermal necrolysis (TEN)

● Histiocytoid Sweet syndrome

Abbreviation: CDK, cyclin-dependent kinase.